AWS re:Invent 2025 - From Lab to Market - AstraZeneca's Enterprise-Wide AI Success Story (IND214)
Why the open web links it
AstraZeneca shares how they scaled AI across their enterprise to accelerate drug development and data innovation.
Linked by 3 independent sites, 2 of them widely read in the 2026-10 crawl of the open web, including amazon.com, zenn.dev, zenml.io.